antimicrobial resistance BioMérieux, Boehringer Ingelheim, Evotec Launch €40M AMR-Targeted Joint Venture Called Aurobac Therapeutics, the joint venture will develop new antimicrobial drugs and companion diagnostics. Illumina Acquires IDbyDNA The firms have had an alliance for the past two years and market a respiratory pathogen panel. SpeeDx RNA/DNA Ratio Method Shows Promise for Bacterial Viability, Susceptibility Testing Premium Branded InSignia, the patented technology will first be incorporated into a gonorrhea antimicrobial susceptibility assay, followed by a point-of-care test. Ares, Sandoz Extend Collaboration on Antimicrobial Resistance Surveillance, Treatment Premium In the collaboration's next phase, the companies plan to develop means to counter AMR through repurposing current antibiotics. BioMérieux Joint Infection Panel Gets FDA De Novo Authorization The 39-target panel runs on FilmArray systems and tests for 31 pathogens implicated in most acute joint infections as well as eight antimicrobial resistance genes. Breaking News Caris Life Sciences Expands Partnership With Epic to Improve Molecular Testing Access Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China New Approach Improves Estimating Cancer Risk From Age-Related Clonal Hematopoiesis T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce The Scan CRISPR's Softer Side A homologous chromosome-templated repair approach to gene editing relies on versions of the Cas9 enzyme that cut a single DNA strand. Pickled? No Problem Researchers come up with an approach for extracting DNA from archived museum specimens. Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. Rise of BA.5 The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.